Search Results

There are 8950 results for: content related to: Chemical Probes for Drug-Resistance Assessment by Binding Competition (RABC): Oseltamivir Susceptibility Evaluation

  1. Chemical Probes for Drug-Resistance Assessment by Binding Competition (RABC): Oseltamivir Susceptibility Evaluation

    Angewandte Chemie International Edition

    Volume 52, Issue 1, January 2, 2013, Pages: 366–370, Dr. Ting-Jen R. Cheng, Shi-Yun Wang, Dr. Wen-Hsien Wen, Dr. Ching-Yao Su, Mengi Lin, Wen-I Huang, Dr. Ming-Tsan Liu, Dr. Ho-Sheng Wu, Nung-Sen Wang, Chung-Kai Cheng, Chun-Lin Chen, Dr. Chien-Tai Ren, Dr. Chung-Yi Wu, Prof. Jim-Min Fang, Dr. Yih-Shyun E. Cheng and Prof. Chi-Huey Wong

    Version of Record online : 13 NOV 2012, DOI: 10.1002/anie.201204062

  2. You have free access to this content
    Neuraminidase inhibitors for preventing and treating influenza in adults and children

    Intervention Review

    The Cochrane Library

    Tom Jefferson, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Igho J Onakpoya, Kamal R Mahtani, David Nunan, Jeremy Howick and Carl J Heneghan

    Published Online : 10 APR 2014, DOI: 10.1002/14651858.CD008965.pub4

  3. You have free access to this content
    Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 7, Issue 5, September 2012, Pages: 1719–1790, Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera and Anthony Harnden

    Version of Record online : 6 SEP 2012, DOI: 10.1002/ebch.1871

  4. You have free access to this content
    Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 3208–3219, Dennis Schade, Jürke Kotthaus, Lukas Riebling, Joscha Kotthaus, Helge Müller-Fielitz, Walter Raasch, Anja Hoffmann, Michaela Schmidtke and Bernd Clement

    Version of Record online : 2 JUN 2015, DOI: 10.1002/jps.24508

  5. Antiviral Agents, RNA Viruses (Other than HIV), and Orthopoxviruses

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Christopher Tseng and Catherine Laughlin

    Published Online : 15 JAN 2003, DOI: 10.1002/0471266949.bmc083

  6. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir

    Journal of Molecular Recognition

    Volume 28, Issue 9, September 2015, Pages: 521–527, Balaji Somasundaram, Conan J. Fee, Rayleen Fredericks, Andrew J. A. Watson, Antony J. Fairbanks and Richard J. Hall

    Version of Record online : 2 MAR 2015, DOI: 10.1002/jmr.2467

  7. You have full text access to this Open Access content
    Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

    Influenza and Other Respiratory Viruses

    Volume 7, Issue s1, January 2013, Pages: 25–36, Jennifer L. McKimm-Breschkin

    Version of Record online : 28 DEC 2012, DOI: 10.1111/irv.12047

  8. Pharmacokinetic Properties ofAnti-Influenza Neuraminidase Inhibitors

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 119–139, Kalayanee Chairat, Joel Tarning, Nicholas J. White and Niklas Lindegardh

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270012440280

  9. Cochrane review: Neuraminidase inhibitors for preventing and treating influenza in children

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 3, Issue 2, June 2008, Pages: 540–582, NJ Matheson, AR Harnden, R Perera, A Sheikh and M Symmonds-Abrahams

    Version of Record online : 3 JUN 2008, DOI: 10.1002/ebch.243

  10. You have free access to this content
    Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

    Intervention Review

    The Cochrane Library

    Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera and Anthony Harnden

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD002744.pub4

  11. Antivirals: Targets and use

    Textbook of Influenza, 2nd Edition

    Michael G. Ison, Alan Hay, Pages: 392–418, 2013

    Published Online : 16 AUG 2013, DOI: 10.1002/9781118636817.ch25

  12. Combating Influenza with Antiviral Therapy in the Pediatric Population

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 1, January 2006, Pages: 95–103, Kara A. Townsend and Lea S. Eiland

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.2006.26.1.95

  13. Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs

    ChemMedChem

    Volume 7, Issue 9, September 2012, Pages: 1527–1536, Dr. Enguang Feng, Dr. Deju Ye, Dr. Jian Li, Dr. Dengyou Zhang, Dr. Jinfang Wang, Dr. Fei Zhao, Prof. Rolf Hilgenfeld, Prof. Mingyue Zheng, Prof. Hualiang Jiang and Prof. Hong Liu

    Version of Record online : 16 JUL 2012, DOI: 10.1002/cmdc.201200155

  14. Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 8, August 2013, Pages: 2450–2459, Alyssa M. Larson, Jianzhu Chen and Alexander M. Klibanov

    Version of Record online : 6 JUL 2013, DOI: 10.1002/jps.23644

  15. Effect of Intravenous Zanamivir on Cardiac Repolarization

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 7, July 2013, Pages: 701–709, Yu Lou, Jianjun Gan, Amanda Peppercorn, Elizabeth Gould, Steve Weller, Stephen C. Piscitelli and Parul Patel

    Version of Record online : 3 APR 2013, DOI: 10.1002/phar.1261

  16. You have free access to this content
    In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors

    Clinical Microbiology and Infection

    Volume 17, Issue 9, September 2011, Pages: 1332–1335, S. Hatakeyama, M. Ozawa and Y. Kawaoka

    Version of Record online : 15 JUL 2010, DOI: 10.1111/j.1469-0691.2010.03313.x

  17. You have full text access to this Open Access content
    Clinical use of approved influenza antivirals: therapy and prophylaxis

    Influenza and Other Respiratory Viruses

    Volume 7, Issue s1, January 2013, Pages: 7–13, Michael G. Ison

    Version of Record online : 28 DEC 2012, DOI: 10.1111/irv.12046

  18. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 3, March 2009, Pages: 1028–1039, Akihiko Kamiya, Masahiro Sakagami and Peter R. Byron

    Version of Record online : 25 JUL 2008, DOI: 10.1002/jps.21501

  19. The pharmacokinetic and safety profiles of zanamivir after single and repeat intravenous administration in healthy Japanese males

    Journal of Clinical Pharmacy and Therapeutics

    Volume 38, Issue 3, June 2013, Pages: 236–240, Y. Shida, K. Hara, S. Nohda, T. Soutome and T. Hirama

    Version of Record online : 14 MAR 2013, DOI: 10.1111/jcpt.12056

  20. Development of a surface plasmon resonance assay to measure the binding affinity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drug zanamivir

    Journal of Molecular Recognition

    Volume 28, Issue 2, February 2015, Pages: 87–95, Balaji Somasundaram, Conan J. Fee, Rayleen Fredericks, Andrew J. A. Watson and Antony J. Fairbanks

    Version of Record online : 20 JAN 2015, DOI: 10.1002/jmr.2417